首页> Scientific reports> Measured intrapatient radiomic variability as a predictor of treatment response in multi-metastatic soft tissue sarcoma patients.

Measured intrapatient radiomic variability as a predictor of treatment response in multi-metastatic soft tissue sarcoma patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Caryn,Geady

第一单位： Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.;Princess Margaret Cancer Research, University Health Network, Toronto, ON, Canada.

作者： Caryn,Geady ^[1] ; James J,Bannon ^[2] ; Shagheyegh,Reza ^[2] ; Laura,Madanat-Harjuoja ^[3] ; Denise,Reinke ^[4] ; Scott,Schuetze ^[4] ; Brian,Crompton ^[5] ; Andrew,Hope ^[6] ; Benjamin,Haibe-Kains ^[7]

作者单位： Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.;Princess Margaret Cancer Research, University Health Network, Toronto, ON, Canada. ^[1] Princess Margaret Cancer Research, University Health Network, Toronto, ON, Canada. ^[2] Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.;Finnish Cancer Registry, Helsinki, Finland. ^[3] Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. ^[4] Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.;Broad Institute of Harvard and MIT, Cambridge, MA, USA. ^[5] Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Andrew.Hope@uhn.ca.;Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. Andrew.Hope@uhn.ca. ^[6] Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. benjamin.haibe-kains@uhn.ca.;Princess Margaret Cancer Research, University Health Network, Toronto, ON, Canada. benjamin.haibe-kains@uhn.ca. ^[7]

关键词 Liquid biopsy Radiomics Treatment response Tumor heterogeneity